Kromek inks expanded deal with Smiths Detection.


Radiation and bio-detection technology specialist Kromek has entered into a distribution agreement with threat detection and security screening provider Smiths Detection, it announced on Monday.

  • Kromek Group
  • 19 December 2022 14:43:55

Source: Sharecast

The AIM-traded firm said that under the deal, Smiths Detection would market and distribute its wearable radiation detection and identification solutions in the Middle East and certain key markets in Asia and Australasia.

That would expand its existing agreement with Smiths Detection, first announced on 7 July, for distribution in the North and South America markets.

To date, the group said it had delivered more than 1,000 detectors under the partnership.

“We are pleased to be expanding our agreement with Smiths Detection to include the distribution and marketing of our solutions to the Middle East and parts of Asia and Australasia,” said chief executive officer Arnab Basu.

“This underscores the strength of our relationship and is a great endorsement of our products.

“With security forces globally requiring increasingly sophisticated solutions to guard against the threats of nuclear terrorism and the illicit movement of materials, the demand for our high-performance nuclear security products continues to grow.”

At 1401 GMT, shares in Kromek Group were up 3.22% at 11.87p.

Reporting by Josh White for Sharecast.com.


ISIN: GB00B1WY2338
Exchange: London Stock Exchange
Sell:
2,334.00 p
Buy:
2,336.00 p
Change: -22.00 ( -0.93 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.